Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1.
BACKGROUND
Arterial aneurysms exhibit a loss of elastin and an increase in the plasminogen activators urokinase plasminogen activator (u-PA) and tissue plasminogen activator (t-PA). Because u-PA, t-PA, and plasmin have a limited proteolytic activity against elastin, the role of plasminogen activators in the aneurysmal disease is unclear. To investigate this question, we overexpressed plasminogen activator inhibitor-1 (PAI-1), an inhibitor of t-PA and u-PA, in a rat model of aortic aneurysm.


RESULTS
Guinea pig-to-rat aortic xenografts were seeded with syngeneic Fischer 344 rat smooth muscle cells retrovirally transduced with the rat PAI-1 gene (LPSN group) or the vector alone (LXSN group). Some grafts were not seeded with cells (NO group). Western blots showed increased PAI-1 in grafts from the LPSN group compared with LXSN and NO groups. All grafts in the NO group (n=8) and 40% in the LXSN group ruptured between days 4 and 14. At 4 weeks in the LXSN group, the remaining unruptured grafts (n=6) were aneurysmal (diameter increase > or =100%), whereas in the LPSN group (n=6) none of the grafts had ruptured or were aneurysmal. Elastin was preserved in the LPSN group. t-PA, the major PA expressed in the model, was decreased in the LPSN group compared with the other groups, as determined by zymography. Quantitative zymography showed decreased levels of two matrix metalloproteinases (MMPs), a 28-kD caseinase, and activated MMP-9 in the LPSN group.


CONCLUSIONS
The blockade of plasminogen activators prevents formation of aneurysms and arterial rupture by inhibiting MMP activation.
Department of Surgery, University of Washington, Seattle 98195-6410, USA.
E
E
Allaire
D
D
Hasenstab
R D
RD
Kenagy
B
B
Starcher
M M
MM
Clowes
A W
AW
Clowes
D000818:Animals; D001011:Aorta / Q000637:transplantation; D001014:Aortic Aneurysm / Q000209:etiology / Q000517:prevention & control*; D001019:Aortic Rupture / Q000517:prevention & control*; D003895:Desmosine / Q000378:metabolism; D004549:Elastin / Q000378:metabolism; D006168:Guinea Pigs; D007114:Immunization; D008297:Male; D008666:Metalloendopeptidases / Q000378:metabolism; D017395:Plasminogen Activator Inhibitor 1 / Q000378:metabolism*; D010960:Plasminogen Activators / Q000378:metabolism; D051381:Rats; D011916:Rats, Inbred F344; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000378:metabolism; D014183:Transplantation, Heterologous
D017395:Plasminogen Activator Inhibitor 1; D003895:Desmosine; D004549:Elastin; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator; D008666:Metalloendopeptidases